Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



AstraZeneca Faces Investigation by PRC, Shares Plummet

December 17, 2024
AstraZeneca, the pharmaceutical giant, is under investigation by the People's Republic of China (PRC) due to allegations of fraud and corruption. This news has caused a sharp decline in the company's shares. The PRC probe has raised serious concerns among investors, leading to a drop in confidence in AstraZeneca's operations. The allegations have also prompted skepticism regarding the company's future prospects, especially in the Chinese market. With this development, it is advisable to seek professional advice from the experts at Stocks Prognosis to understand the forecasted movement of AstraZeneca's shares.

Find out how the ASTRAZENECA PLC rate is expected to change

Get Forecast for AZN

Investor opinions & comments:

I hope AstraZeneca can clear their name and prove these allegations wrong
— from LucasPrice at 12-20-2024 17:52
This investigation by the PRC sounds serious. I wonder what evidence they have against AstraZeneca
— from ProfitPat at 12-20-2024 07:22
AstraZeneca will surely cooperate with the investigation and prove its innocence
— from JoshuaAdams at 12-19-2024 20:48
Despite the investigation, I still have faith in AstraZeneca's long-term success
— from CashClaire at 12-19-2024 01:58
I believe in AstraZeneca's commitment to ethical business practices. They will resolve this issue
— from EliWells at 12-18-2024 00:34
Is there any evidence to support these fraud and corruption allegations? Without proof, it's hard to believe that AstraZeneca is involved in such activities
— from MilaWagner at 12-17-2024 13:06
I'm not sure if these allegations are true. They could just be rumors or competitors trying to damage AstraZeneca's reputation
— from RyanKing at 12-17-2024 12:15
I'm curious to see how this investigation will impact AstraZeneca's business operations in China
— from GrowthGina at 12-17-2024 09:52
I'll wait for more information before making any judgments. AstraZeneca has been a reputable company, so these allegations seem surprising
— from InvestorIvy at 12-17-2024 07:41
If you want to leave a comment, then you need Login or Register





Other news for AZN

AZNMarch 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires  ~1 min.

AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....

AZNMarch 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster  ~2 min.

AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....

AZNMarch 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market  ~1 min.

AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....

AZNMarch 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment  ~2 min.

AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....

AZNMarch 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit  ~1 min.

On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....



Related news

AZNDecember 7, 2024Why AstraZeneca PLC AZN is Revolutionizing the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....

AZNJanuary 1, 2025Stocks Prognosis: Is AstraZeneca PLC AZN Set to Become a U.K. Dividend Champion by 2024?  ~2 min.

AstraZeneca PLC, a leading global pharmaceutical company, is garnering attention from investors as it seeks to establish itself as a U.K. Dividend Champion by 2024....

AZNFebruary 7, 2025AstraZeneca Plc Reports Strong Q4 2024 Earnings, Impressive Growth Prospects in the Pipeline  ~2 min.

AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....

AZNDecember 26, 2024AstraZeneca Faces Investigation in China; Shares Plummet  ~2 min.

AstraZeneca PLC (AZN) shares dropped significantly today following reports of a probe by the People's Republic of China (PRC) into alleged fraud and corruption within the company....

AZNDecember 6, 2024Why AstraZeneca PLC AZN is Poised for Success in the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC (AZN) has emerged as one of the most profitable pharmaceutical stocks in the market....